Emcure Pharmaceuticals Limited — Updates, 01-04-2025: Press Release

Emcutix Biopharmaceuticals Limited has entered an exclusive licensing partnership with WiQo to bring the innovative PRX-PLUS skin tightening solution to India. This strategic alliance allows Emcutix to import, promote, and sell WiQo's patented, non-invasive dermal product, which is already utilized by over 40,000 dermatology professionals worldwide. PRX-PLUS is a needle-free treatment that tightens skin and requires no recovery time, making it suitable for all skin types and ideal for year-round use.

This collaboration aims to significantly enhance the dermatology segment in India, which is valued at approximately USD 1.8 billion and expected to grow at 11-12%. Emcutix's focus on innovative skincare, backed by strong marketing expertise, positions it to redefine the aesthetics landscape in India, potentially transforming consumer access to advanced dermatological solutions. Investors should watch closely as this partnership may substantially boost Emcutix's market presence and revenue potential in the burgeoning skincare sector.